BNOW - BNOW STOCK NEWS

Boon Industries (OTC: BNOW) has filed its first Annual Report on Form 10-K with the SEC for the year ended December 31, 2021. Highlights include a 25% revenue increase year-on-year, a reduction in stockholders' deficit from $197.7 million to $69.4 million, and a 20% increase in net loss. The company raised $607,000 from financing to support its operations. CEO Justin Gonzalez emphasizes a focus on revenue growth in 2022 and the completion of an expanded production facility to enhance distribution capabilities and create new revenue streams.

Boon Industries, Inc. (OTC PINK: BNOW) has completed its production facility in Grass Valley, gaining a certified Good Manufacturing Practice (cGMP) status. The facility can produce over 1,000 gallons of BioDox per day, generating approximately $300,000 in daily revenue, equating to an annual potential of $78 million. Boon anticipates increased sales due to its cGMP status and aims to penetrate further into agricultural and pending EPA-compliant markets, contributing to ongoing revenue growth.

Boon Industries, Inc. (OTC PINK: BNOW) announced that its Form 10 Registration Statement became effective on February 14, 2022, making it subject to the reporting requirements of the Securities Exchange Act of 1934. This filing provides investors with detailed information, including audited financial statements, improving transparency and investment decisions. CEO Justin Gonzalez views this as a pivotal moment for the company as it enters a new phase of production and transparency. Boon's core product, DiOx+, is a chlorine dioxide disinfectant approved by various regulatory agencies, enhancing its market credibility.

Boon Industries, Inc. (OTC PINK: BNOW) is rolling out a comprehensive marketing effort in Q1 2022, leveraging FIFRA 152.6 and CDPR 25(b) provisions to capitalize on market opportunities. The company anticipates full List-N approval from the EPA soon but can commence sales without it. Boon is fulfilling current purchase orders and boasts expanded manufacturing capacity capable of producing 25,000 cases annually, valued at over $10 million. The BioDox pathogen prevention product targets the $180 million agricultural market, focusing on preventing crop loss, with an optimistic sales approach.

Boon Industries, Inc. (OTC PINK: BNOW) announced its partnership with Wallrich Creative Communications to launch its BioDox products in Q1 2022. Wallrich will assist in developing branding and marketing strategies, leveraging their expertise in healthcare and bioscience sectors. Boon aims to deliver eco-friendly solutions, with its flagship product, DiOx+™, a chlorine dioxide disinfectant approved by leading agencies like OSHA and EPA. This product targets medical equipment sterilization and agricultural protection, following 12 years of global usage.

Boon Industries, Inc. (OTC PINK: BNOW) announced the expansion of its facilities, allowing production of DiOx+ and BioDox at an annual capacity of 25,000 cases, with a potential wholesale value exceeding $10 million. This expansion increases their output by over tenfold compared to previous capabilities. Additionally, the company has enhanced its management and sales team to drive product sales and establish partnerships with industry leaders, aiming to secure a stronger market position in the sterilization and agricultural sectors.

Boon Industries, Inc. (OTC PINK: BNOW) announces the impending completion of its new production facility in Grass Valley, California. This facility will enhance production capacity to approximately 500,000 gallons annually, with operations expected to commence in mid-December 2021. Partnering with A&M Labs allows Boon to improve fulfillment capabilities and expand its product offerings. This strategic move aims to service existing large customers more effectively while also targeting new markets.

Boon Industries, Inc. (OTC: BNOW) announces fulfillment of multiple purchase orders for its new BIODOX product line in California's agricultural sector. BIODOX, a proprietary activated chlorine dioxide solution, is approved by the USDA for organic crop use, targeting food safety. The global agricultural disinfectant market is projected to reach USD $2.1 billion by 2026, growing at a CAGR of 3.5%. Chairman Justin Gonzalez highlights BIODOX's potential to increase agricultural yield and profitability, enhancing food safety standards.

Boon Industries, Inc. (OTC PINK: BNOW) announced the initiation of deliveries of its DiOx+™ products while finalizing regulatory EPA registration. The company has partnered with A&M Labs for processing and packaging, enhancing margins and focusing on distribution. An agreement includes a new lease for warehousing near A&M Labs. Additionally, Mr. Johann Loewen has been appointed as Chief Revenue Officer, aiming to bolster sales oversight. Boon also retired 330,000 shares of Preferred A, valued at $3.3 million, amidst strategic changes. DiOx+ is recognized for its efficacy in disinfecting and sterilization.